EX-23.1 3 tm2220235d2_ex23-1.htm EXHIBIT 23.1

EXHIBIT 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2017 Employee Stock Purchase Plan, as amended, of Idera Pharmaceuticals, Inc. of our report dated March 31, 2022, with respect to the financial statements of Idera Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.

 

/s/ Ernst & Young LLP  
   
Philadelphia, Pennsylvania  
July 6, 2022